These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 195342)

  • 21. The short- and long-term effects of bezafibrate in the rat.
    Fahimi HD; Reinicke A; Sujatta M; Yokota S; Ozel M; Hartig F; Stegmeier K
    Ann N Y Acad Sci; 1982; 386():111-35. PubMed ID: 6953842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of clofibrate and gemfibrozil on the activities of mitochondrial carnitine acyltransferases in rat liver. Dose--response relations.
    Kähönen MT; Ylikahri RH
    Atherosclerosis; 1979 Jan; 32(1):47-56. PubMed ID: 465113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on hypolipidemic agents. III. Comparison of the hypolipidemic properties of 5-tridecylpyrazole-3-carboxylic acid and clofibrate.
    Seki K; Fukuda M; Isegawa J; Ohki M
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4103-9. PubMed ID: 6529804
    [No Abstract]   [Full Text] [Related]  

  • 24. Sequential alterations in the micro-localization of catalase in mouse liver after treatment with hypolipidemic drugs.
    Klucis E; Crane D; Masters C
    Mol Cell Biochem; 1984 Nov; 65(1):73-82. PubMed ID: 6521730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased beta-oxidation of erucic acid in perfused hearts from rats fed clofibrate.
    Norseth J
    Biochim Biophys Acta; 1980 Feb; 617(2):183-91. PubMed ID: 6243993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
    Lalwani ND; Reddy MK; Qureshi SA; Reddy JK
    Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of AY-25,712 and other lipid-lowering agents on liver catalase and liver carnitine acetyltransferase in rats.
    Kallai-Sanfacon MA; Cayen MN; Dubuc J; Greselin E; Dvornik D
    Proc Soc Exp Biol Med; 1983 Jul; 173(3):367-71. PubMed ID: 6867010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic peroxisome proliferators induce morphologic transformation of Syrian hamster embryo cells, but not peroxisomal beta oxidation.
    Sanner T; Mikalsen SO; Rivedal E
    Prog Clin Biol Res; 1991; 369():77-89. PubMed ID: 1946545
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tiadenol and clofibrate.
    Berge RK; Bakke OM
    Biochem Pharmacol; 1981 Aug; 30(16):2251-6. PubMed ID: 7295339
    [No Abstract]   [Full Text] [Related]  

  • 31. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats.
    Tamura H; Iida T; Watanabe T; Suga T
    Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of peroxisomal enzymes in livers of neonatal rats exposed to lactating mothers treated with hypolipidaemic drugs. Role of drug metabolite transfer in milk.
    Fahl WE; Lalwani ND; Reddy MK; Reddy JK
    Biochem J; 1983 Mar; 210(3):875-83. PubMed ID: 6683505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial purification and immunoreactivity of an 80 000-molecular-weight polypeptide associated with peroxisome proliferation in rat liver.
    Reddy MK; Hollenberg PF; Reddy JK
    Biochem J; 1980 Jun; 188(3):731-40. PubMed ID: 6781475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation.
    Brandes R; Kaikaus RM; Lysenko N; Ockner RK; Bass NM
    Biochim Biophys Acta; 1990 Apr; 1034(1):53-61. PubMed ID: 2328261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-dependent effects of nongenotoxic hepatocarcinogens on liver apoptosis in vivo.
    Youssef JA; Bouziane M; Badr MZ
    Mech Ageing Dev; 2003 Mar; 124(3):333-40. PubMed ID: 12663131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between the cellular level of long-chain acyl-CoA, peroxisomal beta-oxidation, and palmitoyl-CoA hydrolase activity in rat liver. Are the two enzyme systems regulated by a substrate-induced mechanism?
    Berge RK; Aarsland A
    Biochim Biophys Acta; 1985 Nov; 837(2):141-51. PubMed ID: 2864957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisomal beta-oxidation and catalase activities in fetal rat liver: effect of maternal treatment with clofibrate.
    Cibelli A; Stefanini S; Ceru MP
    Cell Mol Biol; 1988; 34(2):191-205. PubMed ID: 3378247
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in CoA pools in hepatic peroxisomes of the rat under various conditions.
    Horie S; Isobe M; Suga T
    J Biochem; 1986 May; 99(5):1345-52. PubMed ID: 3711067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
    Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
    Digestion; 1979; 19(4):228-36. PubMed ID: 478204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.